PLRZ
Polyrizon Ltd. NASDAQ Listed Oct 29, 2024$13.14
+2.70%
vs $12.80
Mkt Cap $14.7M
52w Low $2.88
67.0% of range
52w High $18.20
50d MA $12.36
200d MA $12.23
P/E (TTM)
—
EV/EBITDA
—
P/B
1.0x
Debt/Equity
0.0x
ROE
-15.9%
P/FCF
-4.7x
RSI (14)
61.30
ATR (14)
$1.26
Beta
-4.55
50d MA
$12.36
200d MA
$12.23
Avg Volume
70.1K
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
5 Ha-Tidhar Street · Ra'anana 4366507 · IL
Data updated apr 26, 2026 7:58pm
· Source: financialmodelingprep.com